Selected research
Industry Growth & Trends
Global DNA Oligonucleotide Synthesis Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global DNA Oligonucleotide Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for DNA Oligonucleotide Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for DNA Oligonucleotide Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA Oligonucleotide Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the DNA Oligonucleotide Synthesis Service market include Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs, Bio Basic, Kaneka Eurogentec SA, AltaBioscience and Synbio Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global DNA Oligonucleotide Synthesis Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The DNA Oligonucleotide Synthesis Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DNA Oligonucleotide Synthesis Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DNA Oligonucleotide Synthesis Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global DNA Oligonucleotide Synthesis Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
DNA Oligonucleotide Synthesis Service Market by Company
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
GenScript
OriGene
BBI
DNA Oligonucleotide Synthesis Service Segment by Type
Standard Oligonucleotides
Micro-Oligonucleotides
Large-scale Oligonucleotides
Degenerate Primers
Long Oligos Synthesis
DNA Oligonucleotide Synthesis Service Segment by Application
Commercial
Academic Research
DNA Oligonucleotide Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Oligonucleotide Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Oligonucleotide Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Oligonucleotide Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of DNA Oligonucleotide Synthesis Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Standard Oligonucleotides
- Micro-Oligonucleotides
- Large-scale Oligonucleotides
- Degenerate Primers
- Long Oligos Synthesis
Applications
- Commercial
- Academic Research
Companies covered
- Genewiz
- Eurofins Genomics
- Gene Oracle
- SBS Genetech
- Creative Biolabs
- Bio Basic
- Kaneka Eurogentec SA
- AltaBioscience
- Synbio Technologies
- TriLink
- Azenta Life Science
- KareBay Biochem
- Creative Biogene
- Generi Biotech
- Primetech
- General Biosystems
- GenScript
- OriGene
- BBI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global DNA Oligonucleotide Synthesis Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global DNA Oligonucleotide Synthesis Service Market Size by Region (2021-2032)
- 1.4.1 Global DNA Oligonucleotide Synthesis Service Market Size by Region (2021-2026)
- 1.4.2 Global DNA Oligonucleotide Synthesis Service Market Size by Region (2027-2032)
- 1.5 Key Regions DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
- 1.5.1 North America DNA Oligonucleotide Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe DNA Oligonucleotide Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America DNA Oligonucleotide Synthesis Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size Growth Rate (2021-2032)
2 DNA Oligonucleotide Synthesis Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Standard Oligonucleotides
- 2.1.2 Micro-Oligonucleotides
- 2.1.3 Large-scale Oligonucleotides
- 2.1.4 Degenerate Primers
- 2.1.5 Long Oligos Synthesis
- 2.2 Global DNA Oligonucleotide Synthesis Service Market Size by Type
- 2.2.1 Global DNA Oligonucleotide Synthesis Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global DNA Oligonucleotide Synthesis Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global DNA Oligonucleotide Synthesis Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global DNA Oligonucleotide Synthesis Service Market Size by Regions
- 2.3.1 North America DNA Oligonucleotide Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe DNA Oligonucleotide Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America DNA Oligonucleotide Synthesis Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa DNA Oligonucleotide Synthesis Service Market Size Breakdown by Type (2021-2026)
3 DNA Oligonucleotide Synthesis Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Commercial
- 3.1.2 Academic Research
- 3.2 Global DNA Oligonucleotide Synthesis Service Market Size by Application
- 3.2.1 Global DNA Oligonucleotide Synthesis Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global DNA Oligonucleotide Synthesis Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global DNA Oligonucleotide Synthesis Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global DNA Oligonucleotide Synthesis Service Market Size by Regions
- 3.3.1 North America DNA Oligonucleotide Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe DNA Oligonucleotide Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America DNA Oligonucleotide Synthesis Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa DNA Oligonucleotide Synthesis Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 DNA Oligonucleotide Synthesis Service Industry Trends
- 4.2 DNA Oligonucleotide Synthesis Service Industry Drivers
- 4.3 DNA Oligonucleotide Synthesis Service Industry Opportunities and Challenges
- 4.4 DNA Oligonucleotide Synthesis Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by DNA Oligonucleotide Synthesis Service Revenue (2021-2026)
- 5.2 Global DNA Oligonucleotide Synthesis Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global DNA Oligonucleotide Synthesis Service Key Company Headquarters & Area Served
- 5.4 Global DNA Oligonucleotide Synthesis Service Company, Product Type & Application
- 5.5 Global DNA Oligonucleotide Synthesis Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global DNA Oligonucleotide Synthesis Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 DNA Oligonucleotide Synthesis Service Players Market Share by Revenue in 2025
- 5.6.3 2025 DNA Oligonucleotide Synthesis Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Genewiz
- 6.1.1 Genewiz Company Information
- 6.1.2 Genewiz Business Overview
- 6.1.3 Genewiz DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Genewiz DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.1.5 Genewiz Recent Developments
- 6.2 Eurofins Genomics
- 6.2.1 Eurofins Genomics Company Information
- 6.2.2 Eurofins Genomics Business Overview
- 6.2.3 Eurofins Genomics DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eurofins Genomics DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.2.5 Eurofins Genomics Recent Developments
- 6.3 Gene Oracle
- 6.3.1 Gene Oracle Company Information
- 6.3.2 Gene Oracle Business Overview
- 6.3.3 Gene Oracle DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Gene Oracle DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.3.5 Gene Oracle Recent Developments
- 6.4 SBS Genetech
- 6.4.1 SBS Genetech Company Information
- 6.4.2 SBS Genetech Business Overview
- 6.4.3 SBS Genetech DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 SBS Genetech DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.4.5 SBS Genetech Recent Developments
- 6.5 Creative Biolabs
- 6.5.1 Creative Biolabs Company Information
- 6.5.2 Creative Biolabs Business Overview
- 6.5.3 Creative Biolabs DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Creative Biolabs DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.5.5 Creative Biolabs Recent Developments
- 6.6 Bio Basic
- 6.6.1 Bio Basic Company Information
- 6.6.2 Bio Basic Business Overview
- 6.6.3 Bio Basic DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bio Basic DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.6.5 Bio Basic Recent Developments
- 6.7 Kaneka Eurogentec SA
- 6.7.1 Kaneka Eurogentec SA Company Information
- 6.7.2 Kaneka Eurogentec SA Business Overview
- 6.7.3 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.7.5 Kaneka Eurogentec SA Recent Developments
- 6.8 AltaBioscience
- 6.8.1 AltaBioscience Company Information
- 6.8.2 AltaBioscience Business Overview
- 6.8.3 AltaBioscience DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 AltaBioscience DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.8.5 AltaBioscience Recent Developments
- 6.9 Synbio Technologies
- 6.9.1 Synbio Technologies Company Information
- 6.9.2 Synbio Technologies Business Overview
- 6.9.3 Synbio Technologies DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Synbio Technologies DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.9.5 Synbio Technologies Recent Developments
- 6.10 TriLink
- 6.10.1 TriLink Company Information
- 6.10.2 TriLink Business Overview
- 6.10.3 TriLink DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 TriLink DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.10.5 TriLink Recent Developments
- 6.11 Azenta Life Science
- 6.11.1 Azenta Life Science Company Information
- 6.11.2 Azenta Life Science Business Overview
- 6.11.3 Azenta Life Science DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Azenta Life Science DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.11.5 Azenta Life Science Recent Developments
- 6.12 KareBay Biochem
- 6.12.1 KareBay Biochem Company Information
- 6.12.2 KareBay Biochem Business Overview
- 6.12.3 KareBay Biochem DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 KareBay Biochem DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.12.5 KareBay Biochem Recent Developments
- 6.13 Creative Biogene
- 6.13.1 Creative Biogene Company Information
- 6.13.2 Creative Biogene Business Overview
- 6.13.3 Creative Biogene DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Creative Biogene DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.13.5 Creative Biogene Recent Developments
- 6.14 Generi Biotech
- 6.14.1 Generi Biotech Company Information
- 6.14.2 Generi Biotech Business Overview
- 6.14.3 Generi Biotech DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Generi Biotech DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.14.5 Generi Biotech Recent Developments
- 6.15 Primetech
- 6.15.1 Primetech Company Information
- 6.15.2 Primetech Business Overview
- 6.15.3 Primetech DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Primetech DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.15.5 Primetech Recent Developments
- 6.16 General Biosystems
- 6.16.1 General Biosystems Company Information
- 6.16.2 General Biosystems Business Overview
- 6.16.3 General Biosystems DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 General Biosystems DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.16.5 General Biosystems Recent Developments
- 6.17 GenScript
- 6.17.1 GenScript Company Information
- 6.17.2 GenScript Business Overview
- 6.17.3 GenScript DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 GenScript DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.17.5 GenScript Recent Developments
- 6.18 OriGene
- 6.18.1 OriGene Company Information
- 6.18.2 OriGene Business Overview
- 6.18.3 OriGene DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 OriGene DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.18.5 OriGene Recent Developments
- 6.19 BBI
- 6.19.1 BBI Company Information
- 6.19.2 BBI Business Overview
- 6.19.3 BBI DNA Oligonucleotide Synthesis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 BBI DNA Oligonucleotide Synthesis Service Product Portfolio
- 6.19.5 BBI Recent Developments
7 North America
- 7.1 North America DNA Oligonucleotide Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 7.3 North America DNA Oligonucleotide Synthesis Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe DNA Oligonucleotide Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 8.3 Europe DNA Oligonucleotide Synthesis Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America DNA Oligonucleotide Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 10.3 South America DNA Oligonucleotide Synthesis Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst